Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer

Conditions: Rectal Cancer Interventions: Drug: liposomal irinotecan; Drug: Capecitabine; Radiation: Radiation threapy Sponsors: Hebei Medical University Fourth Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials